Sericoside
Sericoside has been studied in 1 paper since 2023: 1 trial in people. The newest paper, Jun 12, 2023: “Skin Cellular Reprogramming as an Innovative Anti-Aging Strategy for Cosmetic Application: A Clinical Study of Sericoside”.
See all 1 papers on sericoside
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“the use of sericoside resulted in a 17% increase in skin elasticity”
None of its findings points the other way.
- 1 lab in 1 country
- 4 of 4 findings with company ties
- Human trial1
What did studies of sericoside find?
4Studies of sericoside measured 4 outcomes, among them MKI67, proliferation factor and skin roughness.
MKI67
upin human cells1+85%
1 study
MKI67
upin human cells1+85%
Sericoside increases MKI67 in fibroblasts after 24 hours (+85%).
“Transcriptomic analysis showed that sericoside improved the set of gene expressions involved in cell cycle (+85% MKI67)”
Cellsin fibroblasts after 24 hoursfibroblast0.02%24 hours
Frontiers in bioscience (Landmark edition)
Proliferation factor
upin human cells1+46%
1 study
Proliferation factor
upin human cells1+46%
Sericoside increases proliferation factor in aged fibroblasts (+46%).
“while sericoside increased this proliferation factor by +46%”
Cellsin aged fibroblastsfibroblast0.02%72 hours
Frontiers in bioscience (Landmark edition)
Skin roughness
downin humans1−10%
1 study
Skin roughness
downin humans1−10%
Sericoside decreases skin roughness in humans (versus blank emulsion control) (-10%).
“a 10% reduction in skin roughness”
Human trialversus blank emulsion controlcreamskin0.02%four weeksn = 40
Frontiers in bioscience (Landmark edition)
Skin elasticity
upin humans1+17%
1 study
Skin elasticity
upin humans1+17%
Sericoside increases skin elasticity in humans (versus blank emulsion control) (+17%).
“the use of sericoside resulted in a 17% increase in skin elasticity”
Human trialversus blank emulsion controlcreamskin0.02%four weeksn = 40
Frontiers in bioscience (Landmark edition)